Cambodia’s Ministry of Education Issues Vape Restrictions

Regulations
Jul.01.2022
Concerned over increasing rates of teen vaping, Cambodia’s Ministry of Education has just issued strict guidelines so as to prevent the sale and use of electronic nicotine delivery devices in public and private educational institutions.

Issued by Minister Hang Chuon Naron, the ministry’s directive aims to prevent the use of vaping and heated tobacco products, based on claims that the devices are dangerous to people’s health and pose risks to cardiovascular and respiratory health and also have long-term negative impacts on the brain of developing teens.

 

Cambodia’s Ministry of Education Issues Vape Restrictions

 

The new guidelines ban the use, distribution and advertising of these products on school grounds and surrounding areas, and the Ministry is urging all relevant educational units to collaborate with students’ parents, guardians, educators and students in order to identify and report any e-cigarette sales and distribution sites.

Spokesperson for the Ministry of Health Ly Sovann, said that e-cigarettes are toxic and highly addictive. “The Ministry of Health has banned the import and use of such products such as hookah pipes and e-cigarettes in Cambodia,” he said. Sadly, the relative benefits of the products as safer alternatives to cigarettes and smoking cessation tools are being completely disregarded.

 

Local tobacco warnings

 

Meanwhile, in December 2020 Cambodia’s health ministry asked tobacco companies to change the existing health warnings to new ones determined by the ministry, which did not happen. In July 2021, the ministry reiterated that this standard must be enforced.

The Cambodia Movement for Health (CMH) explained that the Ministry of Health had stated that the warnings should be changed every two years. In line with this, tobacco companies were meant to change the health warning labels in December 2020, which did not happen.

To this effect, last year the CMH reiterated that all cigarette packs must carry the new text and pictures as determined by the ministry, as of August 2021. “If the picture isn’t changed, the effectiveness of the health warning will be reduced because people have become accustomed to the same picture. So, the Ministry of Health decided that the health warning must be changed every two years,” said the CMH.

STIIIZY Redesign Fails to Escape PAX Labs Patent Import Ban as Section 337 Case Also Involves China ALD
STIIIZY Redesign Fails to Escape PAX Labs Patent Import Ban as Section 337 Case Also Involves China ALD
U.S. Customs and Border Protection ruled that STIIIZY had not shown that the redesigned cannabis-vape products covered by its latest request fall outside an ITC limited exclusion order tied to PAX Labs patents. CBP accepted some of STIIIZY’s claim-construction and non-infringement arguments, but the company did not address two additional claims in the same patent. Earlier STIIIZY redesigned cartridges and certain associated components imported with them had received separate CBP clearance.
Sep.16
UK Vape Maker Riot Enters Clacton By-Election to Fight Government 'White Packaging' Proposals
UK Vape Maker Riot Enters Clacton By-Election to Fight Government 'White Packaging' Proposals
British e-liquid manufacturer Riot Labs has introduced a fictional “candidate” called Riot Man around the Clacton parliamentary by-election, seeking to mobilize consumers and retailers against parts of the UK government’s proposed restrictions on vape packaging, device appearance and retail displays. Riot Man is not listed as an official candidate.
Aug.12
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
2Firsts reviewed the original federal court complaint filed by Altria subsidiaries Helix Innovations and NJOY on Sept. 2 challenging FDA’s 2021 PMTA rule. The lawsuit questions whether FDA’s review process complies with the Tobacco Control Act’s 180-day timeline, even as the agency moves to accelerate PMTA reviews and issues more marketing orders. Drawing on the complaint, FDA records, government audits and recent court rulings, 2Firsts examines the legal arguments, supporting evidence and potential implications for the U.S. tobacco review system.
Regulations
Sep.03
Trump Names Darrell Scott as CDC Tobacco Health Adviser, Citing Tobacco Risks and Harm-Reduction Solutions
Trump Names Darrell Scott as CDC Tobacco Health Adviser, Citing Tobacco Risks and Harm-Reduction Solutions
U.S. President Donald Trump has named Pastor Darrell Scott to serve as an adviser on tobacco health issues on the Centers for Disease Control and Prevention’s Advisory Committee to the Director. Trump said Scott would focus on the burden of tobacco-related disease and help examine ways to protect Americans from dangerous tobacco products while supporting solutions that reduce harm. Scott’s public career has largely centered on faith leadership, community advocacy and politics.
Sep.02
Why AIRSCREAM Built its European Production Hub for Regulated Market Growth
Why AIRSCREAM Built its European Production Hub for Regulated Market Growth
AIRSCREAM’s production hub in the Czech Republic brings nicotine pouch manufacturing, e-liquid bottling, product documentation, warehousing and international logistics into one operation, giving brands and commercial partners a practical platform from which to launch, expand and enter new markets.
Market
Sep.16 by 2Firsts Perspectives
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
Cliff Douglas, a veteran U.S. tobacco-control and public health policy figure, told NAS 2026 that the “continuum of risk” should play a central role in tobacco policy. He called for clearer market pathways, stronger risk communication, differentiated regulation and enforcement, and said possible FDA reforms to PMTA reviews could be a “welcome correction” if they create a more efficient, predictable route for scientifically substantiated lower-risk products. Read 2Firsts’ on-site coverage.
Sep.26